参考文献/References:
[1] Flück CE, Nicolo C, Pandey AV. Clinical, structural and functional implications of mutations and polymorphisms in human NADPH P450 oxidoreductase[J].Fundam Clin Pharmacol, 2007,21(4):399-410. DOI:10.1111/j.1472-8206.2007.00520.x.
[2] Pandey AV, Flück CE. NADPH P450 oxidoreductase: structure, function, and pathology of diseases[J].Pharmacol Ther,2013,138(2):229-254.DOI: 10.1016/j.pharmthera.2013.01.010.
[3] Flück CE, Tajima T, Pandey AV,et al. Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome[J].Nat Genet,2004,36(3):228-230. DOI:10.1038/ng1300.
[4] Tzetis M, Konstantinidou A, Sofocleous C,et al. Compound heterozygosity of a paternal submicroscopic deletion and a maternal missense mutation in POR gene: Antley-bixler syndrome phenotype in three sibling fetuses[J].Birth Defects Res A Clin Mol Teratol,2016,106(7):536-541.DOI: 10.1002/bdra.23492.
[5] Krone N, Reisch N, Idkowiak J,et al. Genotype-phenotype analysis in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency[J].J Clin Endocrinol Metab,2012,97(2):E257-E267. DOI: 10.1210/jc.2011-0640.
[6] Flück CE, Mallet D, Hofer G,et al. Deletion of P399_E401 in NADPH cytochrome P450 oxidoreductase results in partial mixed oxidase deficiency[J].Biochem Biophys Res Commun,2011,412(4):572-577. DOI: 10.1016/j.bbrc.2011.08.001.
[7] Sahakitrungruang T, Huang N, Tee MK,et al. Clinical, genetic, and enzymatic characterization of P450 oxidoreductase deficiency in four patients[J]. J Clin Endocrinol Metab,2009,94(12):4992-5000. DOI: 10.1210/jc.2009-1460.
[8] Fukami M, Nishimura G, Homma K,et al. Cytochrome P450 oxidoreductase deficiency: identification and characterization of biallelic mutations and genotype-phenotype correlations in 35 Japanese patients[J].J Clin Endocrinol Metab,2009,94(5):1723-1731. DOI: 10.1210/jc.2008-2816.
[9] Hershkovitz E, Parvari R, Wudy SA,et al. Homozygous mutation G539R in the gene for P450 oxidoreductase in a family previously diagnosed as having 17,20-lyase deficiency[J].J Clin Endocrinol Metab,2008,93(9):3584-3588. DOI: 10.1210/jc.2008-0051.
[10] Scott RR, Gomes LG, Huang N,et al. Apparent manifesting heterozygosity in P450 oxidoreductase deficiency and its effect on coexisting 21-hydroxylase deficiency[J].J Clin Endocrinol Metab,2007,92(6):2318-2322. DOI:10.1210/jc.2006-2345.
[11] Huang N, Pandey AV, Agrawal V,et al. Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis[J].Am J Hum Genet,2005,76(5):729-749. DOI:10.1086/429417.
[12] Fukami M, Homma K, Hasegawa T,et al. Backdoor pathway for dihydrotestosterone biosynthesis: implications for normal and abnormal human sex development[J].Dev Dyn,2013,242(4):320-329. DOI: 10.1002/dvdy.23892.
[13] Idkowiak J, O'Riordan S, Reisch N,et al. Pubertal presentation in seven patients with congenital adrenal hyperplasia due to P450 oxidoreductase deficiency[J].J Clin Endocrinol Metab,2011,96(3):E453-E462. DOI: 10.1210/jc.2010-1607.
[14] Tomalik-Scharte D, Maiter D, Kirchheiner J,et al. Impaired hepatic drug and steroid metabolism in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency[J].Eur J Endocrinol,2010,163(6):919-924. DOI: 10.1530/EJE-10-0764.
[15] 茅江峰,伍学焱,聂敏,等. 第192例阴蒂增大-青春不发育-多囊卵巢-骨骼畸形[J]. 中华医学杂志,2009, 89(46): 3304-3306. DOI:10.3760/cma.j.issn.0376-2491.2009.46.016.
[16] 茅江峰,聂敏伸,高劲松,等. P450氧化还原酶缺陷症的临床表现和羊水穿刺产前诊断的意义[J]. 基础医学与临床,2013,33(1): 24-27.
[17] Pandey AV, Flück CE, Mullis PE. Altered heme catabolism by heme oxygenase-1 caused by mutations in human NADPH cytochrome P450 reductase[J].Biochem Biophys Res Commun,2010,400(3):374-378. DOI: 10.1016/j.bbrc.2010.08.072.